A Markov model of the cost effectiveness of risedronate treatment for prevention of proximal hip, clavicle and forearm fractures by Moehrke, W, Abendroth, K, Kruse, H.-P

Get full text

Cost-effectiveness of risedronate versus ibandronate at one year: The case of Germany by Brecht, J, Pasquale, M, Moehrke, W, Kruse, H

Get full text

Switching from branded alendronate or risedronate to generic alendronate: Effect on persistence with bisphosphonate therapy in Germany by Ziller, V, Schüssel, K, Czeche, S, Franzmann, A, Klöckner, D, Quinzler, R, Schulz, M, Moehrke, W, Hadji, P

Get full text

POS7 COST-EFFECTIVENESS OF RISEDRONATE VS. GENERIC ALENDRONATE: CONSIDERATION OF CALCIUM SUPPLEMENTS by Moehrke, W, Pasquale, M, Moeller, G

Get full text

Significant differences in estradiol bioavailability from two similarly labelled estradiol matrix transdermal systems by Buch, A. B., Shen, L. Z., Kelly, S. C., Russell, D. A., Sahota, R. S., Bixler, C. A., Moehrke, W., Powell, J. H.

Get full text

POS10 PERSISTENCE OF DRUG TREATMENT WITH ALENDRONATE AND RISEDRONATE IN PRIMARY CARE PATIENTS by Moehrke, W, Lyssy, A, Wick, B, Gerd, M

Get full text

POS6 IMPACT OF BISPHOSPHONATES ON OSTEOPOROTIC FRACTURES, PATIENT QUALITY OF LIFE AND TREATMENT COSTS:THE CASE OF GERMANY by Kruse, HP, Kurth, A, Moehrke, W, Lyssy, A, Pasquale, M, Grima, D

Get full text

Influence of Coadministration on the Pharmacokinetics of Azimilide Dihydrochloride and Digoxin by Toothaker, Roger D., Corey, Alfred E., Valentine, Suzanne N., Agnew, Jeff R., Parekh, Nikhil, Moehrke, Werner, Thompson, Gary A., Powell, James H.

Get full text

Oxathiazinane derivatives display both antineoplastic and antibacterial activity: a structure activity study by Majchrzak-Stiller, B., Buchholz, M., Peters, I., Strotmann, J., Möhrke, J., Zelichowski, L., Oehlke, L., Quensel, C., Fein, D., Höhn, P., Müller, T., Uhl, W., Braumann, C.

Get full text

Zur Bakteriolyse der Tuberkelbacillen by Blumenberg, W., Möhrke, W.

Get full text